Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201061604> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3201061604 endingPage "ii26" @default.
- W3201061604 startingPage "ii26" @default.
- W3201061604 abstract "Abstract BACKGROUND Up to 60% of melanoma patients develop brain metastases (BrM). These patients have a poor prognosis and limited treatment options. Immune checkpoint inhibitors (ICI) targeting Cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and Programmed cell death protein-1 (PD-1) have revolutionized the treatment of melanoma and their efficacy has been also demonstrated in melanoma BrM. Our group previously demonstrated that ICI (combined α-PD-1 and α-CTLA-4) enhances chemokine-dependent infiltration of cytotoxic T lymphocytes (CTLs) into melanoma BrMs in preclinical models, accompanied by upregulated expression of T cell attracting chemokines in tumours. Notably, CTLs infiltrating BrM expressed only some of the chemokine receptors (CRs) interacting with ICI-induced chemokines in BrM, providing a rationale to over-express the “missing” CRs in T cells to enhance their homing to tumours in the context of adoptive T cell therapy (ACT). MATERIALS AND METHODS OT-I cells were isolated from OT-I mice and differentiated ex vivo into effector (TEF) and memory (TCM) CD8+ T cells. Tumour infiltrating lymphocytes (TILs) from B16 tumour-bearing mice treated with ICI were isolated using magnetic beads, activated and expanded ex vivo. Expression of CRs and activation markers in ex vivo cultured T cells were quantified by qPCR and/or flow cytometry. The migration of human blood CD8+ T cells towards chemokines of interest were measured in ex vivo migration assays. RESULTS The same CRs that were missing on BrM-infiltrating CTLs in vivo models were also absent from OT-I TEF (CCR7low/CD44high/CD62Llow) and TCM (CCR7high/CD44low/CD62Lhigh) cells, as well as from TILs expanded ex vivo for use in ACT. Furthermore, we observed no increase in migration of human T cells towards chemokines interacting with the “missing” CRs in comparison to the baseline migration, suggesting that these CRs are also absent from human T cells. CONCLUSION Ex vivo expanded T cells that are used in ACT are missing several CRs that are interacting with chemokines upregulated in BrM. We hypothesise that the use of genetically engineered T cells expressing the “missing” CRs in ACT has the potential to enhance ACT efficacy in combination with ICI." @default.
- W3201061604 created "2021-09-27" @default.
- W3201061604 creator A5003257637 @default.
- W3201061604 creator A5009789558 @default.
- W3201061604 creator A5017940329 @default.
- W3201061604 creator A5019878962 @default.
- W3201061604 creator A5041534710 @default.
- W3201061604 creator A5054490697 @default.
- W3201061604 creator A5063439378 @default.
- W3201061604 creator A5074451395 @default.
- W3201061604 creator A5078369847 @default.
- W3201061604 creator A5087416182 @default.
- W3201061604 date "2021-09-01" @default.
- W3201061604 modified "2023-09-26" @default.
- W3201061604 title "P08.02 Harnessing T cells to target brain metastasis" @default.
- W3201061604 doi "https://doi.org/10.1093/neuonc/noab180.089" @default.
- W3201061604 hasPublicationYear "2021" @default.
- W3201061604 type Work @default.
- W3201061604 sameAs 3201061604 @default.
- W3201061604 citedByCount "0" @default.
- W3201061604 crossrefType "journal-article" @default.
- W3201061604 hasAuthorship W3201061604A5003257637 @default.
- W3201061604 hasAuthorship W3201061604A5009789558 @default.
- W3201061604 hasAuthorship W3201061604A5017940329 @default.
- W3201061604 hasAuthorship W3201061604A5019878962 @default.
- W3201061604 hasAuthorship W3201061604A5041534710 @default.
- W3201061604 hasAuthorship W3201061604A5054490697 @default.
- W3201061604 hasAuthorship W3201061604A5063439378 @default.
- W3201061604 hasAuthorship W3201061604A5074451395 @default.
- W3201061604 hasAuthorship W3201061604A5078369847 @default.
- W3201061604 hasAuthorship W3201061604A5087416182 @default.
- W3201061604 hasBestOaLocation W32010616041 @default.
- W3201061604 hasConcept C116484652 @default.
- W3201061604 hasConcept C12823836 @default.
- W3201061604 hasConcept C13373296 @default.
- W3201061604 hasConcept C150903083 @default.
- W3201061604 hasConcept C151872237 @default.
- W3201061604 hasConcept C154317977 @default.
- W3201061604 hasConcept C167672396 @default.
- W3201061604 hasConcept C18903297 @default.
- W3201061604 hasConcept C202751555 @default.
- W3201061604 hasConcept C203014093 @default.
- W3201061604 hasConcept C207001950 @default.
- W3201061604 hasConcept C25532541 @default.
- W3201061604 hasConcept C26291073 @default.
- W3201061604 hasConcept C2776090121 @default.
- W3201061604 hasConcept C2777658100 @default.
- W3201061604 hasConcept C2777701055 @default.
- W3201061604 hasConcept C502942594 @default.
- W3201061604 hasConcept C55493867 @default.
- W3201061604 hasConcept C71924100 @default.
- W3201061604 hasConcept C79484868 @default.
- W3201061604 hasConcept C86803240 @default.
- W3201061604 hasConcept C8891405 @default.
- W3201061604 hasConceptScore W3201061604C116484652 @default.
- W3201061604 hasConceptScore W3201061604C12823836 @default.
- W3201061604 hasConceptScore W3201061604C13373296 @default.
- W3201061604 hasConceptScore W3201061604C150903083 @default.
- W3201061604 hasConceptScore W3201061604C151872237 @default.
- W3201061604 hasConceptScore W3201061604C154317977 @default.
- W3201061604 hasConceptScore W3201061604C167672396 @default.
- W3201061604 hasConceptScore W3201061604C18903297 @default.
- W3201061604 hasConceptScore W3201061604C202751555 @default.
- W3201061604 hasConceptScore W3201061604C203014093 @default.
- W3201061604 hasConceptScore W3201061604C207001950 @default.
- W3201061604 hasConceptScore W3201061604C25532541 @default.
- W3201061604 hasConceptScore W3201061604C26291073 @default.
- W3201061604 hasConceptScore W3201061604C2776090121 @default.
- W3201061604 hasConceptScore W3201061604C2777658100 @default.
- W3201061604 hasConceptScore W3201061604C2777701055 @default.
- W3201061604 hasConceptScore W3201061604C502942594 @default.
- W3201061604 hasConceptScore W3201061604C55493867 @default.
- W3201061604 hasConceptScore W3201061604C71924100 @default.
- W3201061604 hasConceptScore W3201061604C79484868 @default.
- W3201061604 hasConceptScore W3201061604C86803240 @default.
- W3201061604 hasConceptScore W3201061604C8891405 @default.
- W3201061604 hasIssue "Supplement_2" @default.
- W3201061604 hasLocation W32010616041 @default.
- W3201061604 hasLocation W32010616042 @default.
- W3201061604 hasOpenAccess W3201061604 @default.
- W3201061604 hasPrimaryLocation W32010616041 @default.
- W3201061604 hasRelatedWork W1659948457 @default.
- W3201061604 hasRelatedWork W1892403101 @default.
- W3201061604 hasRelatedWork W2052493267 @default.
- W3201061604 hasRelatedWork W2118321819 @default.
- W3201061604 hasRelatedWork W2143314666 @default.
- W3201061604 hasRelatedWork W2146362911 @default.
- W3201061604 hasRelatedWork W2281848537 @default.
- W3201061604 hasRelatedWork W2981079910 @default.
- W3201061604 hasRelatedWork W3201061604 @default.
- W3201061604 hasRelatedWork W4224210543 @default.
- W3201061604 hasVolume "23" @default.
- W3201061604 isParatext "false" @default.
- W3201061604 isRetracted "false" @default.
- W3201061604 magId "3201061604" @default.
- W3201061604 workType "article" @default.